Projects per year
Personal profile
Research interests
Dr. Kebin Hu is the director of nephrology research in the Department of Medicine at Penn State College of Medicine.
Dr. Hu's laboratory is interested in understanding the cellular and molecular mechanisms of tissue fibrogenesis and inflammation, identifying novel signal mediators and developing therapeutic strategies for the treatment of fibrotic or inflammatory diseases.
The hallmark of chronic kidney disease (CKD) is renal interstitial fibrosis and inflammation, which is characterized by proliferation and activation of interstitial cells, florid infiltrations, extensive deposition of extracellular matrix (ECM) components and the eventual destruction of normal kidney structure. Members of plasminogen activator system including tissue-type plasminogen activator (tPA) are the key regulators in the homeostasis of ECM. In addition to its protease activities, Dr. Hu's lab has demonstrated that tPA is actually a cytokine promoting renal fibrosis and inflammation through its receptors-mediated activation of different cascades of intracellular signal transduction.
With the support of grants from federal, state and foundation sources, Dr. Hu's laboratory is currently utilizing integral in vivo and in vitro approaches to:
- define novel signal mechanism underlying p90RSK-mediated kidney fibrosis and inflammation;
- elucidate novel role and signaling of cell-cell communications in kidney fibrosis and inflammation;
- define novel role of FOXO family members, as well as underlying mechanism, in renal fibrogenesis; and
- develop novel and specific therapeutics targeting against CKD.
Teaching and educational interests
Dr. Kebin Hu is a faculty member in the Biomedical Sciences graduate program at Penn State College of Medicine. He is actively involved in small-group education and mentoring of junior faculty, postdoctoral fellows, graduate students and visiting scholars.
Professional information
Dr. Kebin Hu is actively involved in research outreach activities and provides services to the larger scientific communities. Currently, he is a Committee Member for American Heart Association Council on the Kidney in Cardiovascular Disease (KCVD), an Associate Editor for scientific journal Frontiers in Cell and Developmental Biology, and Editorial Board member for peer-reviewed journals including Frontiers in Immunology, Cancers, and Frontiers in Bioscience-Landmark, etc. Dr. Hu regularly reviews grant applications for national and international funding agencies, such as National Institutes of Health and Medical Research Council of United Kingdom, as well as various Foundations.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
PhD, Nanjing University Medical School
… → 2001
MD, Nanjing University Medical School
… → 1997
External positions
Reviewer, NIH Researching COVID to Enhance Recovery (RECOVER) Initiative, National Institutes of Health
2022 → …
Reviewer, NIH Research Initiative on Post-Acute Sequelae of SARS-CoV-2 Infection (PASC), National Heart and Lung and Blood Institute
2021 → …
Member, Special Emphasis Panel, George M. O'Brien Kidney Research Core Centers Program, NIDDK
2017 → …
Ad Hoc Member, Pathobiology of Kidney Disease Study Section, Center for Scientific Review, NIH
2017 → …
Member, Early Career Reviewer Program, Center for Scientific Review, NIH
2014 → 2015
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Projects
- 1 Finished
-
p90 Ribosomal S6 Kinase and Chronic Kidney Disease
National Institute of Diabetes and Digestive and Kidney Diseases
8/10/14 → 5/31/21
Project: Research project
-
Cell–Cell Communication and Extracellular Vesicles in Cancer
Lin, L., Zhou, Y. & Hu, K., May 2023, In: Cancers. 15, 9, 2419.Research output: Contribution to journal › Editorial › peer-review
Open Access1 Scopus citations -
Fibroblast p90RSK induces tubular epithelial transdifferentiation through oxidative stress-mediated β-catenin pathway
Shi, C., Lin, L. & Hu, K., 2023, In: Clinical and Translational Medicine. 13, 1, e1128.Research output: Contribution to journal › Article › peer-review
-
Macrophage Function Modulated by tPA Signaling in Mouse Experimental Kidney Disease Models
Lin, L. & Hu, K., Jul 2023, In: International journal of molecular sciences. 24, 13, 11067.Research output: Contribution to journal › Review article › peer-review
Open Access -
Annexin A2 and Kidney Diseases
Lin, L. & Hu, K., Sep 2 2022, In: Frontiers in Cell and Developmental Biology. 10, 974381.Research output: Contribution to journal › Review article › peer-review
Open Access4 Scopus citations -
REDD1 Ablation Attenuates the Development of Renal Complications in Diabetic Mice
Sunilkumar, S., Yerlikaya, E. I., Toro, A. L., Miller, W. P., Chen, H., Hu, K., Kimball, S. R. & Dennis, M. D., Nov 2022, In: Diabetes. 71, 11, p. 2412-2425 14 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations